* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Dish of the Day
Admissions:
None
Delistings:
None
What’s baking in the oven?
Potential** Initial Public Offerings:***
24th October: Sterling Digital, the bitcoin mining business, has announced its intention to seek Admission on the Access segment of the Aquis Stock Exchange. The Company’s objective is to deliver sustainable long-term growth via compounding bitcoin exposure through cheapest-in-class mining and active management of bitcoin reserves. The Company expects to raise money and Admission on or around 11 November 2025.
Banquet Buffet****
Abingdon Health 7.25p £17.95m (ABDX.L)
The international developer, manufacturer, and regulatory services provider for rapid diagnostic tests and med-tech announces the launch of a seaweed-based alternative housing for its contract development and manufacturing customers for the development and manufacture of lateral flow tests. The Company has agreed an exclusive supply agreement with Wolverhampton based Symbio Technologies Ltd for the supply of compostable bio-based material derived from red-seaweed which can be used to produce lateral flow cassettes via standard injection moulding techniques. This option will provide an alternative to the standard plastic houses that are currently used and create opportunity for Abingdon customers to significantly reduce their plastic waste.
Aura Energy Limited 10.75p £91.87m (AURA.L)
The Parliament of Sweden has voted to overturn its uranium mining ban, which has been in place since 2018, with the lifting of the ban to come into effect on January 1st, 2026. Following this, uranium will be regulated as a concession mineral under the Minerals Act, meaning that it will become embedded within the conventional permit process for mining in Sweden. The change in legislation means that it will be possible to apply for permits to explore for and extract uranium from January 1st, 2026. In September 2023, the Company published a Scoping study for Häggån which was constrained by the uranium mining prohibition. The Company will now examine options to include uranium in its future plans and will increase its investment in exploration activity in Sweden.
Asiamet Resources Limited 1.80p £38.93m (ARS.L)
The Copper-gold Company focused in Indonesia has announced that it has reached an agreement to sell its interest in the KSK Project to Norin Mining (Hong Kong) Limited for gross cash consideration of US$105m (approximately £81m). The sale introduces a well-funded copper producer with specialist skills in copper mine development and processing coupled with high-ESG standards, to advance the Project into mining operations for the benefit of all stakeholders. The sale follows the Company's comprehensive and competitive two-phase strategic review process conducted with multiple well-qualified counterparties.
The Angola-Brazil-focused energy Company has confirmed that further to the announcement made on 30th April 2025, it has now received final ministerial approval of the Environmental Impact Assessment, granting the full Environmental Licence to proceed with seismic acquisition within the KON-16 Block, onshore Angola. In addition, the Company has also confirmed that, further to the announcement of 16th September 2025, it has now signed, through its subsidiary Atlas Petroleum Exploration Worldwide Ltd, a contract with B.G.P. Geophysical Limitada LDA, and BGP INC., China National Petroleum Corporation for all services related to the upcoming 2D seismic acquisition program within the KON-16 Block. With both the Environmental Licence issued, and the BGP contract signed, seismic acquisition operations will commence shortly.
Greenroc Strategic Materials 2.70p £7.14m (GROC.L)
The company focused on the development of critical mineral projects in Greenland has announced that it has signed a purchase agreement with a manufacturing company in China for a line of graphite processing mills and has also signed a rental agreement for a site in Denmark for building and running the pilot plant. The rental agreement has been signed for a facility north of Copenhagen to host GreenRoc's pilot processing plant for active anode material, while the mills are expected to arrive on site during Q1 2026. The Company has also applied for and received the necessary permits for establishing and operating the AAM (active anode material) pilot plant.
Hercules 38.50p £31.03m (HERC.L)
The technology enabled labour supply company for the UK infrastructure and construction sectors has
announced that the Hercules Academy is on course to train 2,000 students in the 2025 calendar year. The Academy, which launched in February 2024 and is situated in the market town of Nuneaton, West Midlands, had planned to train up to 400 new entrants in its first year, but beat expectations after training 1,100 students by February 2025. The Academy is helping address the UK's skills shortage and benefits major infrastructure and construction projects across the UK. Industry training body CITB, as part of its Construction Skills Network report, has forecasted that an additional 225,000 workers will be needed by the industry by 2027 to meet demand.
Rockfire Resources 0.16p £11.05m (ROCK.L)
The base metal, critical mineral, and precious metal exploration Company provided the market with a drilling update from Rockfire's 100%-owned Molaoi zinc deposit in Greece. The drilling of hole HMO-008 has now been completed, which is the first drill hole of the recently commenced resource upgrade to Indicated status. A 2.5m wide zone of visible zinc mineralisation was encountered high in the hole. The highest individual spot sample for zinc is 18.7% Zn. This zone has been cut, sampled and sent to the laboratory for analysis.
Seeing Machines Ltd 3.68p £168.99m (SEE.L)
The advanced computer vision technology Company that designs AI-powered operator monitoring systems to improve transport safety continues to set new standards in automotive safety through its collaboration with Magna, a Tier 1 Automotive supplier. Five years ago, Seeing Machines extended its leading Driver Monitoring System technology to incorporate a wide field of view and include the monitoring of vehicle occupants for enhanced safety and convenience. This Driver and Occupant Monitoring System (DMS/OMS) solution has matured and today is delivered via a single camera, including from the rear-view mirror location behind mirror glass, resulting in an overall lower cost vehicle solution for Automotive OEMs.
Tan Delta Systems 46.00p £18.31m (TAND.L)
The provider of intelligent real time sensor-based monitoring and maintenance systems for commercial and industrial equipment has announced the commencement of a paid for Phase 2 trial by a multi-national online retailer to evaluate Tan Delta's real time oil condition analysis and monitoring systems. The Customer is seeking to monitor critical gearboxes used on conveyor systems inside their distribution centres in order to prevent unplanned downtime and optimise maintenance practices based upon need rather than fixed time schedules. Phase 1 saw the installation and operation of sensor systems on five of their gearboxes in one distribution hub and proved the capability of the Tan Delta solution to detect and track changes in oil and gearbox condition. Phase 2 will see this expanded to more gearboxes in multiple distribution centres, both in Europe and USA along with some data analytic integration. The first purchase order for Phase 2 was received in this month and the actual trial is expected to commence early in 2026.
Verici Dx 0.73p £9.46m (VRCI.L)
The developer of advanced clinical diagnostics for organ transplant announces that it has signed a Provider Participation Agreement with Prime Health Services, a dynamic healthcare technology US based company focused on delivering innovative, data-driven solutions through its Preferred Provider Organization network. PPO networks were established to bring predictability and consistency to pricing in healthcare. They negotiate on behalf of insurance companies to gain discounted pricing, which benefits healthcare companies by bringing a uniform price in reimbursement within the PPO network and fewer denials from insurance reimbursement. It also provides Physicians with greater confidence in ordering as there is more certainty in the cost to their patients which in turn provides greater cost transparency to the patient. The insurance plans also benefit from having the PPO networks successfully negotiate this contracted price from both a cost efficiency perspective as well as competitive appeal.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.